e-Drug3D

743

BICALUTAMIDE


INN
BICALUTAMIDE

cas 90357-06-5
CLASS

ANTINEOPLASTIC
ANDROGEN RECEPTOR ANTAGONISTS
R ENANTIOMER IS ACTIVE
TREATMENT OF METASTATIC CARCINOMA OF THE PROSTATE
REMOVE SOURCE OF ANDROGENS

ROUTE (list)

ORAL

ATC code

L02BB03
L02AE51

PK parameters

Cl 0.32 LITER / HOUR
PPB 96 PERCENT
t1/2 139 HOUR

Solubility

PRATICALLY INSOLUBLE IN WATER AT 37 DEGREE CELCIUS 5 MICROGRAM / MILLILITER


Target

TARGET ANDROGEN RECEPTOR

PDB
4FIA (CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND)

Ligand code = 0U9 (link to the list of PDB complexes)

Download experimental 3D coordinates of 0U9 with added hydrogens

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide

Formula:
C18H14F4N2O4S

Calculated chemical properties:

MW 430.38
NB_atoms 29
XLogP 2.88
PSA 95.575
NB_HD 2
NB_HA 6
fsp3 0.22
Lipinski(0=no;1=yes) 1

FDA
NDA 020498 (label) INN (BICALUTAMIDE) CASODEX (ANI PHARMS) APPROVAL= AP YEAR= 1995
NDA 022310 (label) INN (BICALUTAMIDE) CASODEX (ASTRAZENECA) APPROVAL= AP YEAR= 2008 NEWAPPLICATION
NDA 078575 (label) INN (BICALUTAMIDE) BICALUTAMIDE (SANDOZ) APPROVAL= AP YEAR= 2009
NDA 076932 (label) INN (BICALUTAMIDE) BICALUTAMIDE (TEVA) APPROVAL= AP YEAR= 2009 DISCONTINUED
NDA 077973 (label) INN (BICALUTAMIDE) BICALUTAMIDE (SYNTHON PHARMS) APPROVAL= AP YEAR= 2009 DISCONTINUED
NDA 077995 (label) INN (BICALUTAMIDE) BICALUTAMIDE (KUDCO IRELAND) APPROVAL= AP YEAR= 2009 DISCONTINUED
NDA 078634 (pdf not found) INN (BICALUTAMIDE) BICALUTAMIDE (WATSON LABS TEVA) APPROVAL= AP YEAR= 2009
NDA 078917 (label) INN (BICALUTAMIDE) BICALUTAMIDE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2009
NDA 079089 (label) INN (BICALUTAMIDE) BICALUTAMIDE (ADAPTIS) APPROVAL= AP YEAR= 2009
NDA 079110 (label) INN (BICALUTAMIDE) BICALUTAMIDE (SUN PHARM) APPROVAL= AP YEAR= 2009
NDA 079185 (label) INN (BICALUTAMIDE) BICALUTAMIDE (RISING) APPROVAL= AP YEAR= 2009 DISCONTINUED
NDA 079045 (pdf not found) INN (BICALUTAMIDE) BICALUTAMIDE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2010 DISCONTINUED
NDA 078285 (pdf not found) INN (BICALUTAMIDE) BICALUTAMIDE (ROXANE) APPROVAL= AP YEAR= 2011 DISCONTINUED
NDA 091011 (pdf not found) INN (BICALUTAMIDE) BICALUTAMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2015
NDA 200274 (pdf not found) INN (BICALUTAMIDE) BICALUTAMIDE (APOTEX) APPROVAL= AP YEAR= 2015 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL